ImNO 2024 Abstract Submission


The ImNO Organizing Committee encourages abstract submissions related to biomedical imaging development or application in research areas such as the following:

  • Brain
  • Cancer
  • Cardiovascular
  • Fetal / Placental
  • Musculoskeletal
  • Lung
  • Technical Development
  • Physiology
  • Pre-Clinical Studies
  • Clinical Studies
  • Translation
  • Machine Learning
  • Remote Health


Abstract review process:

  • Abstracts will be reviewed by 3 expert reviewers. Notification of acceptance will be sent to authors on January 15, 2024.
  • Presentations by trainees at the Symposium will be judged for scientific merit and organization, and the top presenters will be awarded monetary prizes. An awards ceremony will be held at the end of the Symposium.
  • Please note: Submission of an abstract constitutes permission for the conference organizers to publish the abstracts in either printed or electronic format.


Mandatory formatting instructions:

  • PDF, one (1) letter-size (8.5x11 inches) page maximum
  • Times New Roman 11-point font
  • All margins must be at least 2 cm
  • Names and affiliations of ALL authors must be listed
  • All abstracts must be searchable
  • Abstracts must follow the format: Introduction, Methods, Results, Conclusions
  • Any figures and/or images must be embedded on the page
  • Title section to include title, authors (indicating presenting author if the presenting author is not the first author), and institutional affiliations of all authors.


    Submission Checklist:

    My title is brief, descriptive, interesting, and avoids jargon.
    I have identified the presenter by underlining their name in the author list if the presenting author is not the first author.
    I have listed the institutional affiliations of all authors.
    I have provided a sufficient background such that an educated but non-expert reader can understand the reason I am performing my study.
    My hypothesis, if stated, is clear and testable. If the study truly has no hypothesis, specific objective(s) are listed in its place.
    I have avoided jargon and uncommon acronyms, or if unavoidable, concisely defined them the first time the terms are used.
    The sections of my abstract flow together, where the Methods address the hypothesis and/or objective(s) identified in the Introduction, the Results are the findings from the Methods I listed, and the Discussion interprets the Results and answers my hypothesis.
    For large studies with multiple outcomes, I have selected only the most important ones that address my primary outcome(s) for inclusion in the abstract.
    I have written or revised my abstract specifically for the ImNO Symposium audience. It is understandable by a scientifically trained but non-expert reader. It has not been copied and pasted from a specialty conference.
    I have edited my abstract to ensure there are no spelling or grammatical errors.
    My abstract adheres to the formatting guidelines outlined.
    I have listed all co-authors, including my supervisors on the CMT submission form.
    I have listed my domain conflicts and all my co-authors' domain conflict, including my supervisor's on the CMT submission form.

    Download Submission Checklist in PDF.

    Abstract Submission:

    All abstracts must be submitted electronically to the Conference Management Toolkit (CMT) paper submission platform no later than Friday, December 1st, 2023, 23:59 Pacific Time.  If you are new to CMT, please refer to the Author's Guide to CMT for detailed instructions. 

    When submitting an abstract you will be asked to select at least three keywords that best describe the research. There are 3 categories of keywords:

    1. Imaging Modalty,
    2. Object of Interest/Area of Application
    3. General Methodology

    Select 1 primary keyword from these categories that best describes your work, and up to 4 secondary keywords. These will be used for selecting reviewers and organizing the sessions.

    Please contact Kitty Wong (kitty.wong [at] for any submission related questions.